Skip to main navigation
Skip to search
Skip to main content
University of Dundee Discovery Portal Home
Search content at University of Dundee Discovery Portal
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Asymptomatic and mild primary hyperparathyroidism
David P. Macfarlane (Lead / Corresponding author)
, Ning Yu
,
Graham P. Leese
Research output
:
Contribution to journal
›
Article
›
peer-review
14
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Asymptomatic and mild primary hyperparathyroidism'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mild Primary Hyperparathyroidism
100%
Sporadic Primary Hyperparathyroidism
100%
Scotland
33%
Epidemiology
33%
Randomized Controlled Trial
33%
Natural History
33%
Tayside
33%
Cardiovascular Risk
33%
Cardiovascular Disease
33%
Intervention Studies
33%
Epidemiological Study
33%
Postmenopausal Women
33%
Parathyroidectomy
33%
Primary Hyperparathyroidism (pHPT)
33%
Renal Stone
33%
Surgical Management
33%
Vertebral Fracture
33%
Population Data
33%
International Guidelines
33%
Hypercalcemia
33%
Neuropsychological Symptoms
33%
Proactive Approach
33%
Routine Blood
33%
Working Diagnosis
33%
Blood Sampling
33%
Medicine and Dentistry
Primary Hyperparathyroidism
100%
Randomized Controlled Trial
25%
Cardiovascular Risk
25%
Cardiovascular Disease
25%
Intervention Study
25%
Cohort Effect
25%
Blood Sampling
25%
Parathyroidectomy
25%
Kidney Stone
25%
Postmenopause
25%
Spine Fracture
25%
Parathyroid
25%
Hypercalcaemia
25%
Surgery
25%
Nursing and Health Professions
Primary Hyperparathyroidism
100%
Practice Guideline
25%
Clinical Audit
25%
Cardiovascular Risk
25%
Cardiovascular Disease
25%
Parathyroidectomy
25%
Nephrolithiasis
25%
Blood Sampling
25%
Hypercalcaemia
25%
Spine Fracture
25%
Kidney Stone
25%
Surgery
25%
Epidemiology
25%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Hyperparathyroidism
100%
Nephrolithiasis
25%
Randomized Controlled Trial
25%
Cardiovascular Risk
25%
Intervention Study
25%
Spine Fracture
25%
Hypercalcaemia
25%
Cardiovascular Disease
25%
Kidney Stone
25%
Epidemiology
25%